Jeff Sorochen

Jeff Sorochen is a seasoned professional in development program management and pharmaceutical sciences, currently serving as Director of Development Program Management at Genmab since May 2023, focusing on Epkinly and Tivdak for various oncology indications. Prior to this role, Jeff held a Global Program Associate Director position at Novartis, overseeing significant projects in BRAF malignancies and CAR-T therapies. Jeff's experience also includes project management in technical operations and validation at Eli Lilly and Company, West-Ward Pharmaceuticals, and DPT Laboratories, showcasing a strong background in biopharmaceutical processes. Jeff's academic credentials include a Bachelor's degree in Pharmaceutical Science from Campbell University and an MBA in Finance from LSU Shreveport.